An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...
NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision medical education." ...
Researchers have identified a gene therapy that could prevent life-threatening arrhythmias by restoring the heart’s ...
Paris, France, February 20, 2025 – EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful ...
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed publication entitled: ...
Given the horror stories I’ve heard of how letters addressed to PBBM tend to disappear in the Bermuda grass in Malacañang, intercepted or undelivered, I thought it best to reprint a very important ...
A GROUP of physicians has urged President Marcos to approve the “next-generation” dengue vaccine as part of the country’s integrated dengue prevention and control strategy. In an appeal letter read by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback